Newsroom
Subscribe to RSS:
-
Now open: Broad Agency Announcements
Now open: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza and Chemical, Biological, Radiological and Nuclear Threats...
- September 25, 2012 -
FDA Public Workshop: Regulatory Science Considerations for Medical Countermeasure Radiation Biodosimetry Devices Sept. 27-28
- September 06, 2012 -
2011 BioShield Annual Report to Congress
- September 06, 2012 -
New HHS contracts enhance pandemic preparedness
- August 20, 2012 -
NIAID issues funding opportunity for treatments for Gastrointestinal Acute Radiation Syndrome
- August 10, 2012 -
Acquisition and Advanced Development of a Colony Stimulating Factor (G- or GM-CSF) for mitigation of neutropenia arising from exposure to ionizing radiation
- June 30, 2012 -
Solicitation Posted: Anthrax Antitoxins for the Treatment of Inhalational Anthrax
- June 28, 2012 -
Pre-applications open: National Center for Advancing Translational Sciences (NCATS) for the “NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules.”
- June 28, 2012 -
Funding opportunity: National Institute of Allergy and Infectious Disease (NIAID) in early stage research for the “Development of Medical Countermeasures for Post-Exposure Mitigation/Treatment of Injuries Resulting from a Radiation/Nuclear Incident.”
- June 25, 2012 -
Acquisition and Advanced Development of a Colony Stimulating Factor (G- or GM-CSF) for mitigation of neutropenia arising from exposure to ionizing radiation
- June 21, 2012 -
PHEMCE Strategy 2012
- June 18, 2012 -
HHS Creates New Centers
- June 15, 2012 -
Anthrax Antitoxins II pre-solicitation notice posted
- June 08, 2012 -
Now open: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza and Chemical, Biological, Radiological and Nuclear Threats
- June 07, 2012 -
HHS support results in international influenza vaccine milestone
- June 04, 2012 -
Synopsis for the Fill-Finish Manufacturing Network Requirement
- April 25, 2012 -
ASPR/BARDA Contract Research Organizations for Clinical Studies Sources Sought Notice posted
- March 22, 2012 -
Midazolam as a Medical Countermeasure for Organophosphorus (OP) Compound Exposure Sources Sought Notice Posted
- February 28, 2012 -
Solicitation: Acquisition of MCMs for Pandemic Influenza Preparedness and Response
- February 03, 2012 -
CBRN BAA Special Instructions: Advanced Development of Definitive Care Products for Thermal Burn Injuries
- January 31, 2012 -
Presolicitation Notice: Acquisition of MCMs for Pandemic Influenza Preparedness and Response
- January 20, 2012 -
HHS aids development of next generation broad spectrum antibiotic
- January 13, 2012 -
Establishing a Fill and Finish Network
- December 12, 2011 -
First U.S. cell-based flu vaccine plant set for dedication
- December 05, 2011 -
BARDA Anthrax Antitoxins Medical Countermeasures Sources Sought Notice
- October 14, 2011 -
Special Instructions to BARDA Broad Agency Announcement (BAA) for Advanced Development of Medical Countermeasures for Pandemic Influenza
- October 04, 2011 -
BARDA Strategic Plan 2011-2016 Released
- September 29, 2011 -
BARDA funds development of five drugs to protect against radiation
- September 29, 2011 -
BARDA supports development of oral radiation drug
- September 23, 2011 -
Making Progress, End to End, in Medical Countermeasures
- September 15, 2011 -
Novel anthrax vaccine and antitoxin being developed with federal support
- September 06, 2011 -
BARDA partners to develop new class of antibiotic
- August 30, 2011 -
BARDA Supports Development of Drugs to Treat Chemical Injury
- August 19, 2011 -
BARDA CBRN BAA: Decorporation instructions expanded in Area of Interest #4
- August 18, 2011 -
Sources Sought Notice Posted for Thermal Burns
- August 01, 2011 -
BARDA supports development of new drugs to treat radiation injury
- July 22, 2011 -
2010 Project BioShield Annual Report to Congress
- July 13, 2011 -
Centers for Innovation in Advanced Development and Manufacturing Amendment 4
- July 07, 2011 -
Centers for Innovation in Advanced Development and Manufacturing Amendment III
- June 22, 2011 -
BARDA Broad Agency Announcement (BAA) for Advanced Research and Development of Personal Protective Equipment, Ventilators, and Diagnostics
- June 10, 2011 -
BARDA Broad Agency Announcement (BAA) for Advanced Research and Development of Personal Protective Equipment, Ventilators, and Diagnostics synopsis
- June 07, 2011 -
Innovation in Advanced Development and Manufacturing: Amendment II posted
- May 31, 2011 -
BARDA funds development of drug to prevent radiation lung injury
- May 27, 2011 -
Second Pre-Proposal Conference (RFP 11-SOL-00011), Centers for Innovation in Advanced Development and Manufacturing
- May 24, 2011 -
Pre Proposal Conference II: June 1, 2011
- March 13, 2011 -
BARDA supports first Project BioShield contract for smallpox drug Contract funds late-stage development, future acquisition of antiviral drug to treat smallpox